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Macrophage colony-stimulating factor is expressed by an ovarian
carcinoma subline and stimulates the c-myc proto-oncogene
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'Department ofInternal Medicine I, Division ofOncology, University of Vienna, WaJringer Gulrtel 18-20, A-1090 Vienna, Austria;
2Ludwig Boltzmann-Institute ofApplied Cancer Research, 3rd Medical Department - Oncology, Kaiser Franz Josef-Hospital,
Kundratstrasse 3,, A-1100 Vienna, Austria.
Smary A small, fast-growing and non-differentiated clone (N.1) derived from the heterogeneous human
epithelial ovarian carcinoma cell line HOC-7 produces an autocrine/paracrine factor that is secreted into the
cell culture supernatant. This factor is capable of enhancing mRNA levels of the proliferation-related
oncogene c-myc in the more differentiated clone D3 and in normal human fibroblasts MRC.5, but also in N.1
cells themselves. Supernatants enriched for this paracrine/autocrine factor also confer a mitogenic stimulus as
measured by [3HJthymidine incorporation. Trypsin can neutralise the stimulating activity of the secreted factor
as well as monoclonal antibodies directed against macrophage colony-stimulating factor (M-CSF). We show
that M-CSF and also M-CSF receptor are expressed in N.1 cells and that recombinant M-CSF induces c-myc
transcript levels in N.1 cells. This investigation raises the possibility that M-CSF might be an autocrine growth
factor in non-differentiated ovarian carcinomas. Inappropriate cytokine production could create a tumour-
promoting microenvironment in this cancer type.
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Ovarian cancer is responsible for the most fatalities among
all gynaecological malignancies, however compared with
other tumour types little is known about epithelial ovarian
carcinomas. Elucidation of the basic biology of this tumour
might be helpful for the development of more efficient
therapeutic strategies.
In order to gain a better understanding of this disease, the
HOC-7 polyclonal human epithelial ovarian adenocarcinoma
cell line, derived from a highly malignant ovarian cancer
(Filmus and Buick, 1985), was characterised (Buick et al.,
1985). Recently homogeneous sublines were isolated (Grunt
et al., 1991a), two of which are the subject of ongoing
investigations. Subline N.l resembles the small morphology
and the fast-growing phenotype of parental HOC-7 cells,
whereas subline D.3 exhibits slow growth and appears to
differentiate spontaneously, expressing a variety of genes cor-
related with an advanced stage of differentiation (Somay et
al., 1992; Grunt et al., 1993a).
As shown previously, the differentiation inducers dimethyl-
sulphoxide (DMSO), dimethylformamide (DMF), transform-
ing growth factor P (TGF-P) and all-trans retinoic acid
(ATRA) can differentiate both the HOC-7 cell line and its
subclone N.1 into a phenotype comparable to that of the
spontaneously differentiated subline D.3 in terms of pro-
liferation rate, cell morphology and protein expression
(Grunt et al., 1991b, 1992a,b, 1993b).
During the characterisation of the HOC-7 sublines, it was
found that N.1 secretes a factor into the culture supernatant
(supe) that autocrinely up-regulates, among others (e.g. plas-
minogen activator-urokinase, pradl oncogene, unpublished
observations) c-myc mRNA transcripts. Subsequently, DNA
synthesis is induced, thus the autocrine factor is conferring a
mitogenic stimulus. It was found that the parental cell line
HOC-7 produces cytokines typical of monocyte-macrophage
lineages, such as constitutively expressed interleukin 6 and
interleukin 1 and interleukin 8 upon stimulation with ATRA
(unpublished observations). In this investigation the auto-
crne activity will be restricted to a limited number of possi-
ble factors.
Correspondence: G Krupitza, Ludwig Boltzmann-Institute of Applied
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Materials and methods
Chemicals andprobes
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) cDNA
was donated by Paul Amstad, ISREC, Lausanne, Switzer-
land; c-myc exon 3-specific cDNA came from Rainer DeMar-
tin, VIRCC, Vienna, Austria; c-fms cDNA, which detects
human macrophage colony-stimulating factor receptor (M-
CSFR) was from the American Type Culture Collection
(Cat. No. 59293; ATCC, Rockville, MD, USA).
[3H]thymidine (1 LCigl l'; 5-10 Ci mmol-l; Dupont-NEN,
Wilmington, DE, USA) was kindly donated by Ernst
Mfillner, VBC, Vienna, Austria.
Human recombinant macrophage colony-stimulating factor
(M-CSF) was purchased from Genzyme (Cambridge, MA,
USA), monoclonal anti-M-CSF rat IgG from Oncogene
Science (Manhasset, NY, USA), aprotinin from Bohringer
(Mannheim, Germany) and trypsin (cell culture grade) from
Gibco (Paisley, UK). Phorbol 12-myristate 13-acetate (TPA)
was purchased from Sigma (St Louis, MO, USA), casein
kinase I inhibitor CKL-7 and protein kinase A (PKA)
inhibitor H-89 from Seikagaku (Tokyo, Japan) and genistein
from Upstate Biotechnology (Lake Placid, NY, USA).
Cell culture
Normal human lung fibroblasts MRC.5 (ATCC) and the
human ovarian adenocarcinoma sublines N.l and D.3
(Somay et al., 1992; Grunt et al., 1993a), which were isolated
from the HOC-7 heterogenous cell line (Buick et al., 1985;
Grunt et al., 199la), were kept in alpha-minimum essential
medium (MEM) (Gibco) and the human leukaemia cell line
HL-60 in RPMI-1640 (Gibco), all of which were supp-
lemented with 10% heat-inactivated fetal calf serum (FCS,
Gibco) at 37C in humidified atmosphere, containing 5%
carbon dioxide. Maintenance cultures were split 1:30 (N.1)
and 1:15 (D.3), whereas cell cultures subjected to experiments
were split appropriately to achieve the different states of
confluence at the day of manipulation. For Northern blot
analysis cells were grown in T-25 flasks (Falcon). Cells sub-
jected to (3H]thymidine incorporation were grown in six-well
plates (Costar).G Knra eta
Conditioning of supernatants: Cell supernatants used to
study transcription kinetics were obtained as folows: N.1
cells were split 1:20 into 10% FCS containing alpha-MEM.
Supernatants used as negative controls were taken from N.1
cells that were grown to 80-90% confluency (2.6-2.8 x 105
cellscm-) and those used for [Hjthymidi incorporation
were obtained from D.3 cells (used as negative controls) and
N.1 cells (used as the source of the autocrine activity) grown
in 10% FCS containing alpha-MEM until reaching
confluence.
The medium was then aspirated and cell monolayers
exhaustingly rinsed with prewarmed PBS (Phosphate-buffered
saline) in order to remove all traces of serum. Prewarmed
alpha-MEM (free of serum and additives) was then applied
to cells (day zero) and left in a 37C humidified 5% carbon
dioxide containing atmosphere to become conditioned.
Initially, starting from day zero, supernatants were checked
every other day for their capability to induce C-myc trans-
cription (monitored by Northern blot analysis). On average,
N.1 conditioned supernatants enriched in c-myc-inducing
activity were obtained from day 10 on, whereas D.3 condi-
tioned supernatants remained inactive.
Both cell lines remained healthy during this starvation
period. We did not observe cell detachment or substantial
accumulation of debris. Upon refeeding after such extended
periods of starvation, they resumed normal growth (unpub-
lished observations).
Conditioned supernatants which contained 10% FCS (used
routinely) and which were capable of inducing oncogene
transcription were derived from cells that just reached
confluence or had already been confluent for 1 or 2 days.
They were cleared of any possible debris by short centrifuga-
tion, aliquoted and stored at -80C.
[3H]thymidine incorporation
D.3 control and N.1-inducing supernatants (supematants of
both cell lines were conditioned for 11 days in the absence of
FCS after reaching confluence) were applied onto 50-60%
confluent N.1 cell cultures and the cells exposed for 4, 6, 8,
18 and 26 h. [3H]thymidine (2#Ci ml-') was added to each
culture well (0.5 ml of medium) for a pulse label of 2 h.
Subsequently, the supernatants were discarded, the cells
rinsed once with ice-cold alpha-MEM and twice with ice-cold
PBS, followed by cell lysis using 0.5% SDS, 20 mm EDTA.
Lysates were ethanol precipitated and DNA measured by
spectrophotometry (A" readings). The same amounts of
[3Hjthymidine-labelled DNA samples were analysed by sci-
tillation counting.
Northern blot analysis
Induction of transcription: Conditioned supernatants were
applied onto 80% confluent N.1 cell cultures. Supernatants
derived from 80% confluent cells served as negative controls.
The treatment times are given in the figure leends.
Experiments were terminated by discarding the conditioned
culture medium and quickly rinsing the monolayers twice
with ice-cold PBS and subsequently lysing cells by the addi-
tion of 1 ml of RNAzol (BioTex, Houston, TX, USA).
All solutions and buffers coming into contact with RNA
were steilised. Thirty micrograms of total RNA per slot was
separated using formaldehyde-contig agarose gels at 4-C
(80 V constant voltage). Gels were soaked in 50 mM sodium
hydroxide, 100mM sodium chloride for 30mi, equilibrated
for 30min in 100mM Tris pH 7.5 and subsequenty for
30min in 2 x SSC ( x SSC= 150mM sodium chloride,
15 mM sodium citrate, pH 7.0). Separated RNA was transfer-
red to Immobilon S membranes (Millipore, Bedford, MA,
USA) by the capillary method using 10 x SSC as the trans-
porting phase. Filters were prehybridised in a buffer contain-
ing 7% SDS, 1% BSA, 0.5% pyrophosphate, 10mg ml-'
salmon sperm DNA and 500 mM sodium phosphate pH 7.2
for 2h. This buffer enhances sensitivity 5-to 10-fold by
limiting high backgrounds. Biotinylated probes were added at
a concentration of 20 ngml-' to the buffer used for prehyb-
ridisation (GAPDH only at a concentration of 3 ngml-1),
and allowed to hybridise to the filter-bound RNA at 6TC
overnight. Filters were further processed according to the
instructions given by the manufacturer (PolarPlex detection
kit, Millipore). Blocking and washing steps were extended
severalfold. Processed filters were exposed for 10-90 min to
Kodak X-ray films (Rochester, NY, USA).
Biotinylation of DNA probes using the PolarPlex labelling
kit (Millipore) was done by a modified procedure. Random
primers and cDNA probes were boiled together for 5 mi,
then quickly chilled on ice, dNTPs and Kkenow fragment
added and the synthesis reaction allowed to continue for 6 h
at 15'C.
This procedure resulted in labelled fragments which were
similar in size to unlabelled cDNA probes and exhibited
improved sensitivity and specificity.
Reverse transcnption-polymerase chai reaction (RT-PCR)
Total RNA from N.1 cells was extracted using RNAzol. A
100 zg aliquot of RNA was incubated with 100 U of DNAse
(free of RNAse, B6hringer Mannheim,) in a buffer contain-
ing 10mM magnesium chloride, 20U of RNAse inhibitor
(Invitrogen, San Diego, CA, USA) and 20 mM Tris pH 7.6
for 1 h at room temperature in a 100p1 reaction, in order to
destroy trace impurities of genomic DNA. Subsequently,
DNAse-treated RNA preparations were re-extracted with
RNAzol, precipitated, dissolved in water and 1 pg of RNA
was reverse transcribed using the cDNA cycle kit of Invit-
rogen according to the manufacturer's instructions. Five per
cent of the reverse transcript was used for PCR using the
M-CSF ampr set of Clontech Laboratories (Palo Alto,
CA, USA) and Taq-polymerase (Cetus, Norwalk, CT, USA).
The primer pair sequence used was synthesised according to
Kacinski et al. (1990).
PCR was performed for 40 cycles using gandard condi-
tions.
Res
Distinct c-myc expression ofN.] andD3 cells
Since growth of D.3 cells is arrested upon achieving
confluence, whereas the N.1 subhne continues to proliferate
and begins to shed ls into the medium, we compared
constitutive c-myc expression of N.1 and D.3 sublines. While
c-nyc mRNA levels diminish in confluent D.3 cells over time,
the N.1 subline maintains unchanged constitutive transcript
expression (see Figure 1).
Autocrine/paracrine stimuation ofc-myc expression
We next wanted to examine if constitutive c-myc expression
in N.1 cells was due to an autocrine feedback stimulation. In
order to test this hypotheis, we harvested supematants of
N.1 cultures that had rahed confluence the day before (ID
confluent = 3.2-3.6 x I05 cellscm-2, details are given in the
Materials and methods section) and these supenatants were
reapplied onto monolayers of D.3 and MRC.5 cells. For
control purposes, we used culture medium conditioned by
subconfluent N.l ceils (2.6-2.8 x 105 cellscm2, approx-
imately 80-90% confluent), as well as conditioned medium
derived from D.3 and MRC.5 cells (Figure 2). Whereas
supernatants of I day confluent N.1 cells were capable of
inducing expression in both D.3 and MRC.5 cells (Figure 2,
lanes 1 and 5), conditioned supernatants of I day confluent
D.3 and MRC.5 cells could not elicit such a stimulation
(Figure 2, lanes 3 and 7). Figure 3 shows that supenatants
conditioned by confluent N.1 cells, to our surprise, also
up-regulated c-myc mRNA expression in subconfluent N.1
cells.
The rather controversial observation that conditioned
medium from confluent N.1 cells can stimulate c-myc expres-AiorinS inaI o Om wm
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Fgwe 1 Constitutive levels of c-myc and GAPDH mRNA dur-
ing different stages of cell culture confluence. Subconfluent =
mRNA expression of 70% subconfluent; confluent =just
confluent; ID confluent and 2D confluent= 1 day and 2 day
confluent cels respectively. Thirty micrograms of total RNA
extracted from slow-growing D.3 cells (left) and fast-growing N.1
cells (right) was applied to each lane and probed against c-myc
(top), stripped and reprobed against GAPDH (bottom).
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F e 2 Up-regulation of c-myc mRNA in the slow-growing
subline D.3 and in human normal fibroblasts MRC.5. Super-
natants conditioned by N.A cells (lanes 1 and 5), D.3 cells (lane 3)
and MRC.5 fibroblasts (lane 7) which reached confluence the day
before and from N.1 cells (lanes 2 and 6), D.3 cells (lane 4) and
MRC.5 fibroblasts (lane 8) which were still subconfluent were
applied to D.3 cells and to MRC.5 fibroblasts (b). Filters were
stripped and rehybridised against GAPDH (bottom).
sion in subconfluent N.1 cells, whereas the same medium
failed to stimulate mRNA levels in confluent N.1 cells, from
which the inducing supernatants had been derived (compare
Figure 3 with Figure 1), reveals a new aspect of c-myc
transregulation and has to be followed in an independent set
of experiments.
The N. 1-secreted activity stimulates DNA synthesis
Incorporation of radiolabelled thymidine into replicating
DNA is a very sensitive method of studying mitogenic
Figue 3 Kinetic of autocrine factor-induced c-myc mRNA ex-
pression. Lane CO-, 80% subconfluent N.A cells were exposed to
supernatant conditioned by 80% N.1 cells for 5 h; lanes 0.5-7,
80% subconfluent N.1 cells were exposed to supernatant condi-
tioned by 2 day confluent N.1 cells for 0.5-7 h respectively.
Filters were hybridised against c-m;c (a), stripped and rehyb-
ridised against GAPDH (b).
stimuli. In order to exclude serum-biased [3Hlthymidine
incorporation, the experiments described below were per-
formed with control (D.3) and stimulating (N.1) supernatant
that had been conditioned in the absence of any proteins or
additives (i.e. pure alpha-MEM). N.l-stimulating and
D.3 control supernatants (both conditioned for 11 days in the
absence of FCS) were applied onto 60% confluent N.1 cells
(2 x I05 cells cmn-) for 4, 6, 8, 18 and 26 h (Figure 4). For
each time point the same amount of [3H]thymidine was
added 2 h before terminating the incorporation reaction.
The DNA content for each reaction was determined and
incorporated activity was standardised to the same amounts
of DNA. Maximal induction (10-fold above the control level)
elicited by N.1 conditioned supernatant occurred 6h after
application, i.e. 2-3 h before peak of c-myc mRNA
accumulation. The thymidine incorporation data clearly dem-
onstrate that stimulation by the secreted factor only allows
for one single round of cell division, otherwise the effect
would not decline to control levels within 26h. We have
previously shown that N.1 cells have a doubling time of 24 h
(Somay et al., 1992). These data indicate a functional relation
between c-myc transcriptional induction by autocrine factors
and cell proliferation of the N.1 ovarian carcinoma subline.
The autocrinefactor is susceptible to protease inactivation
Preincubating conditioned supernatants with trypsin
(10ILgml]') for 2h resulted in complete inhibition of the
c-myc-inducing activity (Figure 5, lane 3). Inhibition of tryp-
sin itself by aprotinin (50 ;g ml-') restored the effect (Figure
5, lane 4). Aprotinin was added to both the positive and
negative controls to exclude non-specific aprotinin-mediated
interactions (Figure 5, lanes 1 and 2). Thus the c-myc-
inducing factor is apparently a protein.
Macrophage colony-stimulatingfactor and its receptor are
expressed by N.J cells
A number of growth factors, cytokines and steroid hormones
are produced by a variety of ovarian carcinoma cell lines. We
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Fgure 4 Incorporation of [H]thymidine by N.l ceUs. Alpha-
MEM was conditioned for days by confluent D.3 ceUs (0)
and N.l ceUls (-) and applied to 60% confluent N.l cells. Cells
were stimulated for the times indicated and pulsed with
LH]thymidine for 2 h just before termination of the experiment.
Incorporated radioactivity (c.p.m.) of the individual samples was
normalised by the corresponding amount of isolated DNA. The
experimental points shown are the calculated average of triplicate
determinations.
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Figue 5 Inactivation of c-mvc-stimulatory N. I supernatants by
trypsin, monitored by Northern blotting. Conditioned super-
natant derived from overconfluent N. cells (lane 1) which was
preincubated either with trypsin for 2 h at 37C (lane 3) or with
trypsin + aprotinin for 2 h at 37C (lane 4) was applied onto
subconfluent N. I cells. Non-stimulating supernatant from sub-
confluent N. cells served as a control (lane 1). Aprotinin was
added as indicated in lanes 1 and 2 in order to avoid non-specific
effects of this trypsin inhibitor. Filters were probed against c-myc
(top), stripped and rehybridised against GAPDH (bottom).
Figure 6 Amplification of N.1 reverse transcripts by polymerase
chain reaction (PCR). (a) cDNA of N.1 ceUs (lane 4) was sub-
jected to PCR using a M-CSF-specific primerpair (Clonetech
Laboratories) that allows amplification of a 437 bp fragment, as
shown with a control cDNA (lane 3), which was provided by the
manufacturer. (b) cDNA of N.I cells was amphfied with a primer
pair which is specific for M-CSF receptor (M-CSFR, lane 2) and
which produces a 519 bp fragment, as shown with control cDNA
(from ATCC, lane 3). In both panels, water was used as a
negative control. Msp-restricted pBR322 DNA was used as size
marker. DNA was separated on a 6% polyacrylamide gel and
stained with ethidium bromide.
tried to detect some of them (not shown) and found by
RT-PCR that M-CSF is expressed in N.1 cells (Figure 6a)
as well as M-CSF receptor (Figure 6b).
To prove a contribution of M-CSF to c-myc stimulation,
conditioned supernatant was preincubated with rat monoc-
lonal antibodies (IgG) specific for M-CSF (3ig ml-) at 4°C
ovemight and then applied to subconfluent N.1 cells. The
control supernatant was preincubated with non-immune rat
IgG (10flggml') to rule out non-specific antibody effects
(Figure 7a, lane 3). Anti-M-CSF antibody abolished c-myc
induction in N.1 cells (Figure 7a, lane 4). The specificity of
the antibody was confirmed by neutralising the c-myc
stimulatory activity of M-CSF-supplemented (200
unitsUml-1) alpha-MEM (compare lanes 5 and 6, Figure
7a). Genistein (50 iM final concentration) completely
inhibited constitutive c-myc expression and also autocrine
factor-induced stimulation. On the other hand, inhibition of
protein kinase A (PKA) by H-89 (500 nM final concentration)
generally increased c-myc expression but had no separate
effect on factor-induced c-myc transcript levels. Ckl-7
(10 mM final concentration), an inhibitor of casein kinase I,
abolished the inducibility of autocrine factor-mediated c-myc
stimulation (Figure 7b).
Dicssiom
The fast growing subclone N.1 maintains unchanged levels of
constitutive c-myc transcripts, whereas subclone D.3, which is
slow-growing, down-regulates c-myc mRNA levels after
reaching confluence. Constitutive c-myc expression as is
observed in N.1 cells is typical of highly transformed, con-
tinuously proliferating cancer cells (Hann et al., 1985; Edel-
man et al., 1987) and has been shown to be a major factor
inhibiting the differentiation processes (Resnitzky et al., 1986;
Spotts and Hann, 1990).
In this report we demonstrate that the undifferentiated N.1
subline secretes an autocrine factor which stimulates DNA
synthesis, whereas the well-differentiated sublime D.3 does
not. N.1 conditioned supernatants induce transcription of the
c-myc proto-oncogene in D.3 cells and in MRC-5 human
normal lung fibroblasts in a paracrine fashion, but also
autocrinely in N.1 cells themselves. We believe that the
factor-triggered c-myc stimulation by conditioned super-ANN add d ce
G Krupiza eta
.0 Q
*-~ LL LL
co L)
,
c ._1 ._1
ac c
L. 05 L- LL ILL
o o 0 0 CO) C)
v c L)
LL) U.
28S-
18 S-
18 S-
_ c-m
-GAP
I 3 4 5
b o
C; 0
U)
2 3 4
._
.5 r40
m @c
+
28S-
18S-s
18S -
7 (a) Re ofc-myc ta ipt nducio
CSF antibodies. Subconfluent N.J1 cds were induces
natant ofoverconfluent N.l cells (lane 1), with supen
cubated with rat monocknal anti-M-CSF IgG (lan
non-immune rat IgG as a control (lane 3). Lane Z
c-myc N cells exposed to non-stima
natant. Iane 6, N.J cells which were exposed to hi
binant M-CSF. Before applcation to N. cells, hu
binant M-CSF was premncubated with rat monock
CSF IgG (lane 5). (b) Modulation of cons
supernatant-n c-myc mRNA expression by;
signal trndtion Eighty per cent confluent N.
exosed to inactive control supernatants (-) and
supernatants ( + ) for 4h each. Then inhlbitors wer
the incubation aElowed to continue for another 2
Control, i.e. no inhibitors panel 2, addition of H-
inhlbitor of protein kinase A; panel 3, addition 4
specifc inhibitor of casein kinase I; pand 4, addition
an inhibitor of tyrose kinases. After hybriisatiom
probe filters were stipped and rehybrilised with (
natants of overconfluent N.1 cells, which autocr
subconfluent N.1 cells, is kept in check by an
c-myc down-regulator under normal growth coI
actiation of this repressor seems to be trailin
idcng signal provided by the secreted auto
otherwise, an accumulation of c-myc mRNA in c
N.l cells would be observed as is the case with induced
subconfluent cells.
Little is known about ovarian autocrine biochemisty,
however some autocrine and paracrine factors generated by
ovarian cancers have been described. Two main classes can
be distinguished: steroid hormones, such as 17p-oestradiol
and progesterone (for review see Rao and Slotman, 1991)
and proteins such as insulin-like growth factors (IGFs), (Yee
et a!., 1991), platelet-derived growth factor (PDGF), (Hen-
riksen et al., 1993), M-CSF (Baiocchi et al., 1991; Berchuk et
al., 1992), TNF (Naylor et al., 1993; Wu et al., 1993),
transfoming growth factor alpha (TGF-a), (Kurachi et al.,
1991), IL-I (Li et al., 1992) and IL-6 (Watson et al., 1993).
In our case a contribution to c-myc stimulation by steriod
KC hormones could be ruled out because the autocrine activity
was protease sensitive.
It was found that M-CSF and its receptor, the c-fins
oncogene, are both expressed in N.A cells and thus this could
result in a perpetual autocrine growth stimulus as sug
by Malik and Balkwill (1991).
'DH Baiocchi et al., (1991) and Wiener et al., (1992) showed that a high percntage of epitheial ovarian carcinomas exp-
ress M-CSF and the c-fins oncogene, and Bast et al. (1993)
proposed that inappropriate signalling by tyrosine kinases
(such as c-fins) causes growth of ovarian cancer cells, which
can be r sed upon modulation of tyrosine kinase activity.
It seems that M-CSF and particularly c-fins expresson are
general phenomena in ovarian cancer biology and might
correlate with progression.
It has previously been demonstrated for macrophage cell
ines that M-CSF up-regulates c-myc transcript levels (Chen
and Rohrschneider, 1993; Xu et al., 1993). The results pres-
ented here show that, in analogy with the proposal of Bast et
al. (1993), M-CSF-and superatant-induced c-myc expres-
sion in the ovarian cancer subine N.l can be reversed by
antibodies directed against M-CSF. Moreover, genistein, an
ce- C-myc inhl-itor of tyrosin kinae-mediated signals, bkcs auto- -c-myc ~crme factor-idcd cmyc up-regulation. It is interesting to
note that casein kinase I also seems to play a nt role
in tho tr*ne""n nf thP ctminlotrrv mional wrnvide hv the 11LI= uaI5ULAUtUVVI :>1U= W}iuakl asm. FIvVI Uy LU.
N.l secreted factor, whereas PKA is not involved.
When c-myc expression is stimulated by all-trans retinoic
acid (ATRA), N.l cells kept in low serm concentrations
undergo apoptosis (Krupitza et al., in press). Progrmmed
GAPDH cell death also occurs when N.A conditioned medium (free of
FCS and therefore free of survival factors) is reapplied to
subconfluent N.l cells. Before cell death the growth arrest-
specific gene 6 (gas6) becomes down-regulated (unpublished
wtbytanti-M- data), which also occurs during ATRA-induced apoptosis.
d withspper- These findings that c-myc induction in N.A cells
nat4a)ntPfai"h triggers high metabolic activity, just as apoptosis is a highly
u
4) orwith active process depending on c-myc expression.
latorgsut M-CSF has been given in addition to cisplatin in
aman rm chemotherapy for ovarian cancer. Susuld et al. (1994) found
man rem- that M-CSF caused t of platekt recovery in this
onal anti-M- therapeutic regimen and suggted that this effect could be
titutive and the cause of the iproved therapeutic effect We can predict
inhibitors of from our cell culture experments when c-myc stimulation
to k wereg will result in DNA synthesis and when (depending on the
toadeing presence of survival factors) it will result in apoptosis. We
2h. Pand 1: cannot, however, predict the effects that M-CSF may have
89, a speific on ovarian carcnoma cells in the intact organism.
of CKI-7, a
ofgnisen,
i with c-myc
APDH.
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